Research on infections caused by bacteria and how to fight them. Covers antibiotic resistance, biofilms, congenital syphilis, Lyme disease, and precise treatments.
A study found that gut bacteria can predict the risk of life-threatening blood infections following high-dose chemotherapy in cancer patients. The researchers created an algorithm that uses bacterial DNA sequencing to identify good and bad bacteria, predicting infections with around 85% accuracy.
A new catheter infection alert system could prevent serious infections in millions of hospital patients and elderly people. The system changes the color of urine to detect bacterial blockages before they cause kidney failure and death.
An intervention at a Canadian acute care facility screened and isolated asymptomatic C. difficile carriers, leading to a 50% decrease in health-care associated infections. The study estimated that the intervention prevented approximately 63 cases, suggesting a cost-effective strategy for preventing C. difficile infection.
Researchers found that combining great willow herb extracts with antibiotics can reduce antibiotic doses and minimize side effects in treating multi-drug resistant infections. The synergistic effect of the herb's phenolic acids and flavonoids with common antibiotics has potential to influence antimicrobial activity.
Researchers found that polyandry in house mice does not enhance immune resistance against Salmonella infection. However, male mice showed surprising resistance to the disease, with lower bacterial loads compared to females.
Parasitic worms, or helminths, have been found to beneficially influence the composition of gut microbiota in individuals with inflammatory bowel disease. By infecting mice deficient in a gene that models Crohn's disease, researchers discovered that these parasites restore a compromised layer of mucus and intestinal cell morphology.
Researchers at Wayne State University are developing novel aminoglycoside antibiotics with reduced toxicity and decreased resistance, aiming to combat multidrug-resistant diseases. The project, led by David Crich, will evaluate synthetic compounds in vitro and animal models for efficacy and antibacterial activity.
Researchers at UC San Diego School of Medicine are establishing an interdisciplinary center to define the systems biology of antibiotic resistance, a pressing global medical challenge. The program aims to develop new strategies for treating antibiotic-resistant infections by combining experimental and computational methods.
Scientists have discovered a new way to inhibit the growth of Mycobacterium tuberculosis by using modified cholesterol as an energy source. This breakthrough holds promise for the development of new treatments for tuberculosis, a highly infectious lung disease that kills one person every 21 seconds.
Monophosphoryl lipid A (MPLA) has shown protective effects in mice with burn injuries, stimulating G-CSF production to bolster immune cells' ability to fight bacteria. Increased neutrophil levels mediate this protection.
A new method has been proposed to detect bacterial infections in preterm infants by monitoring serum procalcitonin levels. The study found that PCT levels take longer to return to normal in preterm infants, providing a potential early detection criterion.
Researchers at Nanyang Technological University (NTU) have discovered a method to disrupt cell-to-cell communication and latch-on ability of bacteria, making them vulnerable to antibiotics. This breakthrough offers new treatment options for chronic bacterial infections and may help extend the lifespan of existing drugs.
A new study found that nonpathogenic viruses can be transferred during fecal transplants, but these viruses appear to be harmless to humans. The researchers analyzed fecal transplants from a single donor to three children with chronic ulcerative colitis and found mostly temperate bacteriophages were transmitted.
A new study from the University of Texas Medical Branch at Galveston finds that higher rates of breastfeeding and vaccination significantly reduce the incidence of ear infections in babies. The study also suggests that lower smoking rates contribute to this decline.
Researchers have identified 122 new types of RNA bacteriophages in diverse ecological niches, providing an opportunity to define their contributions to ecology and explore them as novel tools. The study suggests that RNA bacteriophages likely play a much larger role in shaping the bacterial makeup of worldwide habitats than previously ...
A new study reveals that bacteria in biofilm form are stronger than single-celled bacteria and outcompete them for nourishment. This challenges the traditional view of bacterial infections and highlights the importance of treating biofilms as a distinct entity.
A study found that contact lenses alter the natural microbial community of the eyes, making it more skin-like. This shift in bacterial composition increases the risk of eye infections such as giant papillary conjunctivitis and keratitis.
The emm59 clone of group A Streptococcus has been identified as the cause of a deadly outbreak in Arizona and the Southwest. This hypervirulent strain is directly related to a previous Canadian outbreak, which evolved into the current southwestern US epidemic.
A study led by the University of Edinburgh's MRC Centre for Inflammation Research discovered a mechanism to keep bacteria in the gut. The researchers found that PGE2 activates innate lymphoid cells, which help maintain the gut barrier and prevent body-wide inflammation.
Scientists at Umea University have discovered chemical compounds that attenuate Listeria monocytogenes virulence without killing the bacteria, reducing resistance risks. The findings provide a promising platform for developing new antimicrobial strategies against this foodborne pathogen.
Researchers identified uropathogenic E. coli as the E. coli type most strongly linked to pre-term infant mortality from necrotizing enterocolitis. The study suggests that early identification of this bacteria could help physicians make informed care decisions for vulnerable infants.
Researchers found that viruses opt for 'piggyback-the-winner' strategy, integrating into hosts to reduce replication and avoid immunity defenses. This model better explains virus-host dynamics during microbial population booms.
A global review of 58 studies involving over 77,000 E. coli samples found a high prevalence of antibiotic resistance in children's urinary tract infections, particularly in non-OECD countries. Previous antibiotic use increased the risk of resistance for up to six months after treatment.
A study by Pavel Kovarik and his team at the University of Vienna reveals that type I interferons play a crucial role in regulating IL-1β levels, preventing excessive inflammation and balance in the immune system.
Researchers identified two synthetic compounds that can restore the effectiveness of antibiotics against MRSA by blocking an enzyme involved in bacterial cell wall production. When paired with existing antibiotics, these compounds significantly improved survival rates and reduced infection severity in mice infected with MRSA.
A team of researchers is using computational models and data from actual patients to understand C. difficile colonization and infection. They aim to develop tools to prevent and treat infections that kill thousands annually.
Researchers at St. Jude Children's Research Hospital found that maternal bacterial infections trigger abnormal proliferation of neurons in the fetal brain, leading to changes in cognitive functioning and increased risk of autism. Treatment with antibiotics like ampicillin may exacerbate these effects.
E. coli bacteria attach to the surface of the urinary tract via protein FimH, binding more tightly under flow conditions. This discovery could lead to development of FimH antagonists, reducing antibiotic use and resistance.
A new class of 'BH3-mimetic' drugs has shown promise in treating Legionella-infected cells by targeting the BCL-XL protein. This research could lead to new treatments for various bacterial infections, even those resistant to antibiotics.
A new study found that premature infants' gut bacteria are vulnerable to antibiotic resistance, with almost 800 genes identified, including those associated with carbapenem-resistant Enterobacteriaceae. The study suggests that routine antibiotic use in preterm infants may not be effective and could lead to increased infection risk.
Researchers report unusual rugby injuries, including acetabular fractures and hip dislocations in young players. A man also developed distorted vision after inhaling poppers for the first time. Additionally, a patient developed a rare liver abscess after routine dental cleaning.
Recent research on cystic fibrosis lung infections highlights the ability of Pseudomonas aeruginosa to adapt and evolve in chronically infected patients. The review suggests that understanding this evolution is crucial for developing alternative treatment strategies to minimize symptoms and improve patient outcomes.
Researchers at the University of Exeter have created a vaccine that offers high-level protection against melioidosis, a bacterial infection that causes pneumonia and sepsis. The new vaccine, which has been tested on mice, holds promise for preventing a disease that affects thousands in tropical regions and is often misdiagnosed.
Researchers at St. Jude Children's Research Hospital identified an enzyme that aids pneumococcus survival by removing its capsule, making it harder to be detected and destroyed by the immune system. This discovery has profound implications for treatment and vaccine strategies to combat invasive pneumococcal disease.
Engineered fabrics effective against superbugs like MRSA could reduce impact of super-bacterial infections. Researchers have successfully produced anti-super-bacterial masks using violacein-based dye, blocking growth by 99.9%.
Researchers at EPFL have developed a technology that accelerates scarring and prevents bacterial growth, aiming to reduce the death rate among victims of serious burns. The new bandage combines biological bandages with dendrimers to destroy microbes and prevent infections.
A study published in Nature Communications has discovered that genes can move from chlamydia strains in the eye to sexually transmitted strains, allowing them to infect the eye and cause Trachoma. This revelation challenges previous beliefs about Chlamydia evolution and highlights the potential for new variant Trachoma strains to emerge.
Researchers at the University of Southampton found that copper can destroy MRSA bacteria by damaging their DNA and respiration, making it difficult for them to survive. This discovery explains why touch surfaces made from solid antimicrobial copper are effective in reducing the spread of infections.
A new methodology developed at Rice and Rutgers universities helps scientists understand how biochemical networks control biological responses. The approach predicted novel interactions in bacteria that cause tuberculosis, revealing a potential mechanism for the disease's survival.
Researchers have provided a molecular blueprint of Globomycin, an antibacterial candidate with promise in stemming the post-antibiotic tide. The blueprint may aid the design of better globomycin analogues and explore thousands of new antibiotic solutions to common infections.
The study reveals novel adaptations and traits in infectious species of Leptospira that help illuminate its evolutionary history and provide new preventive and treatment approaches. It identifies key pathogen-specific features, including the CRISPR-Cas genetic machinery, which are unique to pathogenic Leptospira.
Scientists have uncovered the 3D structure of an enzyme crucial for Mycobacterium tuberculosis survival. This discovery could lead to the development of new compounds targeting the ketol-acid reductoisomerase (KARI) enzyme, which is only present in bacteria and plants.
A new study found that no disinfectant completely removes bacterial biofilms from dental water lines, posing a significant infection risk. Researchers recommend preventing the formation of biofilms as key to keeping lines clean, and suggest using good quality water, prevention disinfectants, and avoiding stagnation.
Researchers found that certain bacteria, including Francisella tularensis and Salmonella enterica, can spread rapidly throughout the body by interacting with immune cells called macrophages. This process, known as trogocytosis, allows bacteria to evade detection and survive inside infected cells.
A study published in PNAS reveals that genetic variations in the Tie2 gene are associated with an increased risk of developing life-threatening vascular complications following infections. Higher Tie2 levels provide protection against these complications.
Researchers identified the genetic 'map' of the human parasitic scabies mite using cutting-edge genome technologies, which could lead to new ways of preventing and treating scabies infestations. The study also found that certain animal strains of mites may infect humans, with major implications for disease control programs.
A Phase 1b/2 trial suggests that an oral therapeutic drug containing the spores of beneficial bacteria is effective for preventing recurrence of C. difficile infection and restoring a healthy gut microbiome. The treatment achieved a 96.7% clinical cure rate, comparable to open-label antibiotic trials and fecal microbiota transplants.
A new electrochemical detection strategy can identify bacteria in wounds in under a minute, allowing for targeted therapies and reduced healthcare costs. The method uses pyocyanin, a molecule produced by Pseudomonas bacteria, to detect infections.
Researchers identify RimK as a crucial regulator of bacterial movement, which is essential for initiating infections. Disabling this protein significantly reduces the ability of bacteria to infect plants and humans, offering a new target for anti-infective drugs.
Researchers discovered a bacterial immune system that waits until viruses replicate before attacking them, allowing for more efficient defense. This new strategy, called type III CRISPR-Cas, takes up to nine hours to clear infections and has potential applications in biotechnology and medicine.
Exposure to specific antibiotics is linked to the development of antibiotic-resistant C. difficile , one of the fastest growing bacteria superbugs. The study found that fluoroquinolone and macrolide exposure was more frequent in patients with a highly resistant strain, supporting targeted antibiotic stewardship monitoring programs.
A 15-year study in Kilifi, Kenya found that vaccination reduces the chance of Hib disease by 93% and provides long-lasting protection. The current vaccine schedule is effective without a booster dose, suggesting no need for extra doses.
A national survey reveals that high school wrestlers are prone to skin infections, with the head and neck being the most frequent site. Most skin infections can be treated within three to six days, but some may have more serious eye and neurological involvement.
Researchers have discovered a natural clay deposit that exhibits strong antibacterial activity against the ESKAPE group of bacterial pathogens, including MRSA and other antibiotic-resistant strains. The clay, named Kisameet clay, has been used for centuries by indigenous communities to treat various ailments.
A study published by the Society for Healthcare Epidemiology of America found that long-term use of antiseptic soap in bathing critically ill patients did not cause high levels of resistance in bacteria on their skin. The prevalence of MRSA-resistant strains decreased after starting chlorhexidine (CHG) bathing.
Researchers identified hypervirulent strains of Listeria monocytogenes associated with human infections, which are more invasive and infect central nervous system and fetus more often than those linked to food. The study used large-scale analysis of epidemiological, clinical, and microbiological data.
Researchers found that ancient medicinal clay exhibits potent antibacterial activity against ESKAPE strains of bacteria, including Enterococcus faecium and Staphylococcus aureus. The rare mineral clay may provide a new treatment option for serious infections caused by these resistant pathogens.
Researchers have identified over 13,000 Zika cases in Colombia, with the country now second only to Brazil in reported infections. The team is exploring ways to control the spread of the virus using a bacterium that infects mosquitoes, aiming to prevent transmission and mitigate serious consequences like microcephaly.
A team of biologists at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours. The approach allows doctors to rapidly identify the appropriate treatment for patients with life-threatening bacterial infections, potentially slowing the emergence of drug resistance.
Researchers at Duke University Medical Center have developed a gene signature test that accurately determines whether a respiratory illness is caused by infection from a virus or bacteria. The test shows high accuracy in classifying patients with flu viruses and other common infections.